Table 1.
Mortality and severe COVID-19 disease in pediatric oncology patients with COVID-19
| Patients (N) |
Deaths (N) |
Severe COVID (N) |
Location [Reference] |
Publication date |
|---|---|---|---|---|
| 33 | 0 | *5 (15%) | France [6] | May-2020 |
| 37 | 1 (3%) | *5 (14%) | France [15] | Nov-2020 |
| 59 | 0 | No ICU/oxygen mentioned | Pakistan [16] | April 2021 |
| 7 |
3 (43%) (1 related to cancer progression) |
3 (43%) | Egypt [17] | Oct-2020 |
| 57 | 2 (4%) | 6 (11%) | Texas [18] | Mar-2021 |
| 20 | 0 |
0 (4 hospitalized) |
New York [19] | May-2020 |
| 16 | 0 | 4 (25%) | New York [20] | Jun-2020 |
| 6 | 0 | 0 | [7] | Jun-2020 |
| 10 | 0 | 0 | Italy [8] | Jun-2020 |
| 98 | 4** (4%) | 7 (7%) | New York/New Jersey [3] | Dec-2020 |
| 18 | 0 | 0 | Russia [21] | May-2021 |
| 1749 | 65 (3.7%) | 152 (8.7%) | 50 countries worldwide [2] | Sept 2021 |
| 29 | 0 | 0 | Italy [9] | Jul-2020 |
| 19 | 0 | 2 required oxygen (11%) | Madrid [10] | May-2020 |
| 10 | 0 | 0 | Saudi Arabia [22] | Nov-2020 |
| 20 |
4 (20%) |
3 ICU (15%) | Iran [23] | Jul-2021 |
| 33 | 5 (15%)*** | 7 (21%) | Columbia [24] | May-2021 |
| 38 | 3 (8%)*** | 2 ICU (5%) | Mexico [25] | Dec-2020 |
| 47 | 2 | 11 (23%) | Spain [26] | Jul-2020 |
| 15 | 0 | 1 (7%) | India [27] | Nov-2020 |
| 37 | 0 | 14 (38%) | India [28] | Mar-2021 |
| 1196 | 51 (4.3%) | 83 (7%) | USA [1] | Sept 2021 |
| Total: 3554 | 140 (4%) | 305 (9%) |
*Appear to be same data set in two different papers
**Deaths not attributed to COVID-19
***Part of the cohort death not attributed to COVID-19